期刊文献+

骨肉瘤中PTEN的表达及意义 被引量:2

EXPRESSION AND SIGNIFIANCE OF PTEN GENE IN HUMAN OSTEOSARCOMA
下载PDF
导出
摘要 目的:探讨PTEN在人骨肉瘤、骨软骨瘤中表达的生物学意义及其互相关系。方法:选取30例人骨肉瘤标本,以骨软骨瘤为对照,采用免疫组化S-P法,探讨PTEN在人骨肉瘤、骨软骨瘤中的阳性表达及其与肿瘤分组、分级的关系。结果:①骨软骨瘤组PTEN阳性表达率为90.0%(9/10),骨肉瘤组阳性表达率为70.0%(21/30),两者染色阳性率差异无统计学意义(P>0.05),染色强度比较差异有统计学意义。②骨肉瘤Ⅰ级组阳性表达率为85.7%(6/7),Ⅱ、Ⅲ级组阳性表达率为65.2%(15/23),Ⅱ、Ⅲ级组与Ⅰ级组染色阳性率和染色强度相比,差异无统计学意义(P>0.05)。③骨肉瘤各型间染色结果比较差异无统计学意义(P>0.05)。结论:骨肉瘤的发生与PTEN异常表达有关;PTEN不可作为骨肉瘤的恶性分级、增殖的指标。 Objective:To explore the biological significance and the relationships of the PTEN genes in Osteosarcoma tissues(OST)and osteo-chondroma tissues(OCT).Method:30 specimens of human OST were obtained.The control groups were 10 cases OCT.Immunohistochemical S-P method was used to investigate the relationships of these genes in OST and OCT.Result:①In OCT,the positive immunostaining rate of PTEN was 90.0%(9/10).In OST,it was 70.0 %(21/30).Comparing the staining rate,there had no significant differences(P>0.05);on the staining intensity,there had significant differences(P<0.05).②In grade I of OST,the positive immunostaining rate of PTEN was 85.7%(6/7).In grade Ⅱ、Ⅲ of OST,the rate was 65.2 %(15/23).Comparing the positive staining rate and intensity,there had no significant differences(P > 0.05).③ Comparing the staining result of PTEN,there had no significant differences(P > 0.05)among every sort.Conclusion:PTEN cloud play an important role in the genesis of OS.;PTEN could not be a maker of classification and proliferation of OS cells.
出处 《中医正骨》 2008年第9期14-14,16,共2页 The Journal of Traditional Chinese Orthopedics and Traumatology
关键词 骨肉瘤/生理病理学 PTEN蛋白 抑癌基因 实验研究 Osteosarcoma/physiology,pathophysiology,PTEN protein,Tumor suppressor gene,empirical study
  • 相关文献

参考文献9

  • 1PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation[J]. Eur J Cancer,.2006,42(10) : 1491.
  • 2刘子君 吉重敏 黄承达 等.骨肉瘤的病理组织学分型与预后的关系.中华肿瘤学杂志,1983,5:340-2.
  • 3刘昌茂 陈志让 杨玖生 等.骨肉瘤157例临床病理分析.实用病理学杂志,1987,1:1-2.
  • 4Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells[J]. J Cell Biochem,2003,90(5):964.
  • 5荆俊杰,章翔,吴景文,刘先珍,曹卫东,樊启涛,段光明.星形细胞瘤中PTEN和CB表达与侵袭性的关系[J].第四军医大学学报,2000,21(9):1109-1111. 被引量:8
  • 6姚勤,戴淑真,车艳辞,徐冰.子宫内膜癌组织中PTEN蛋白的表达及其临床意义[J].实用癌症杂志,2002,17(5):512-514. 被引量:7
  • 7李航,张祥福,王川,吴黎敏,蔡庆发.肿瘤抑制基因PTEN在胃癌中的表达及其临床意义[J].实用肿瘤杂志,2002,17(5):301-303. 被引量:9
  • 8Whang YE, Wu X, Suzuki H, et al. Inanfivation of the tumor supressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression(J). Proc Natl A cad Sci USA, 1998,95(9) :5246.
  • 9Levine RA,Forest T,Smith C.Tumor suppressor FFEN is mutated in canine osteosarcoma cell lines and tumors[J]. Vet Pathol,2002,39(3) : 372.

二级参考文献18

  • 1[1]Li J, Yen C, Law D,et al. PTEN,a putative protein tyrosine phosphatase gene mutated in human brain, breast,and prostate cancer[J]. Science, 1997,275(13): 1943.
  • 2[2]Steck PA, Pershouse MA,Jasser SA, et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J ]. Nat Genet, 1997,15(4): 356.
  • 3[3]Li DM,Sun H.Tep1,encoded by a candidate tumor suppressor transforming growth factor β [J ]. Cancer Res,1997,57(11) :2124.
  • 4[4]Li J, Simpson L, Talahashi M, et al. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene[J ]. Cancer Res, 1998,58(24): 5667.
  • 5[5]Tamura M, Gu J, Takino T, et al. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth:differential involvement of focal adhesion kinase and p130cas[J ]. Cancer Res, 1999,59(2): 442.
  • 6[6]Gu J, Tamura M, Yamada KM . Tumor suppressor PTEN inhibits integrinand growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways[J ] .J Cell Biol, 1998,143(5): 1375.
  • 7[7]Kurose K,Bando K,Fukino K,et al. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers:evidence for inactivation of both alleles[J ].Jpn J Cancer Res, 1998,89(8) :842.
  • 8[8]Risinger JI, Hayes K, Maxwell GL,et al. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics [J]. Clin Cancer Res, 1998,4(12): 3005.
  • 9[9]Whang YE,Wu X,Suzhki H,et al. Onactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression[J ]. Proc Natl Acad Sci USA, 1998,95(23) :5246.
  • 10[10]Salvesen HB, MacDonald N, Ryan A, et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma[J ]. Int J Cancer, 2001,91 (1): 22.

共引文献26

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部